Introducing… The Newly Redesigned RS 3400 The world’s premier blood irradiator just raised the bar on dose uniformity, productivity and throughput. Beautiful. Simple. Easy to use.
The Premier Blood Irradiator in the World
Over 20 years ago, we pioneered the first-ever FDA-cleared blood x-ray irradiation medical device used to prevent TA-GVHD, and we have maintained our status as the industry leader and gold-standard in blood irradiation technology and instrumentation ever since. Our patented x-ray irradiation technology effectively and routinely inactivates the immune cells in donor blood, which diminishes the risk of developing TA-GVHD for the transfusion recipient.
Patented Quastar® Photonic Decontamination™ Technology
The Newly Redesigned RS 3400 is a registered medical device with a US FDA 510(k). It is produced and tested in Rad Source’s Buford Georgia, USA facility. Rad Source products conform to the radiation safety guidelines found in 21 CFR 1020.40. Radiation safety features of the RS 3400 include redundant safety interlocks to prevent intrusion into the radiation chamber while in operation. The unit is a Cabinet X-Ray System that has external emissions far below the Federal Standard for such devices.
Highest Product Throughput and Volume Available
Processes a variety of blood configurations of up to 6L capacity in 5 minutes – whole blood bags, platelet bags and loaded syringes in the same cycle.
Excellent Dose Uniformity
Combination of the patented Quastar® x-ray emitter, rotating carousel, and new canister with Support Inserts may achieve as low as 1.6~1.35 DUR.
Direct Replacement for Gamma Irradiator
U.S. Government recognized safe, direct alternative – for radioactive isotope (gamma) source irradiators.
*RS 3400 is 21-FDA cleared and CE marked.
RS 3400 Series
- The Newly Redesigned RS 3400 is a registered medical device with a US FDA 510(k).
- It is produced and tested in Rad Source’s Buford Georgia, USA facility.
- Rad Source products conform to the radiation safety guidelines found in 21 CFR 1020.40.
Latest News & Studies
Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR
Abstract: Common chromosomal fragile sites are unstable genomic loci susceptible to breakage, rearrangement, and are highly recombinogenic. Frequent alterations at these loci in tumor cells led to the hypothesis that they may...
Abstract: The liver is a site where activated CD8(+) T cells are trapped and destroyed at the end of an immune response. The intrahepatic accumulation of activated murine TCR transgenic CD8(+) T cells was significantly reduced...